December 26, 2017
- Auromedics Pharma LLC Issues Voluntary Nationwide Recall of Linezolid Injection 600mg/300ml, due to Presence White Particulate Matter that has been Identified as Mold
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drugs@FDA Data Files (updated)
- FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response
- Generic Drug User Fee Amendments (updated)
- Oncologic Drugs Advisory Committee Roster (updated)
- Patent Certifications and Suitability Petitions (updated)
- Public Meetings: Enhanced Drug Distribution Security under the Drug Supply Chain Security Act (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario